Titanium-nitride-oxide-coated Titan-2 bioactive coronary stent: A new horizon for coronary intervention

Expert Review of Medical Devices

Volumn 7, Issue 5, 2010, Pages 599-604

  Karjalainen, Pasi P ^a   Ylitalo, Antti ^a   Airaksinen, Juhani Ke ^b   Nammas, Wail ^c  

^a SATAKUNTA CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c Saint Fatima Square Heliopolis   (Egypt)

Author keywords

bioactive stents; drug eluting stents; in stent restenosis; percutaneous coronary intervention; stent thrombosis

Indexed keywords

BIOACTIVE STENTS; DRUG-ELUTING STENTS; IN-STENT RESTENOSIS; PERCUTANEOUS CORONARY INTERVENTION; STENT THROMBOSIS;

ARTIFICIAL ORGANS; BIOCOMPATIBILITY; BLOOD VESSELS; DISEASES; TITANIUM; TITANIUM NITRIDE; TITANIUM OXIDES;

HEART;

CLOPIDOGREL; FIBRIN; PACLITAXEL; STAINLESS STEEL; TITANIUM DERIVATIVE; TITANIUM DIOXIDE; TITANIUM NITRIDE OXIDE; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ARTERY INTIMA PROLIFERATION; BARE METAL STENT; BIOCOMPATIBILITY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; EPITHELIZATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; IN-STENT RESTENOSIS; MATERIAL COATING; MORTALITY; NONHUMAN; PATIENT SAFETY; PHYSICAL CHEMISTRY; RECURRENT DISEASE; REVIEW; RISK REDUCTION; STENT THROMBOSIS; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT FAILURE; TREATMENT RESPONSE;

CLINICAL TRIALS AS TOPIC; COATED MATERIALS, BIOCOMPATIBLE; CORONARY RESTENOSIS; HUMANS; STENTS; TITANIUM;

EID: 77956466755     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.10.44     Document Type: Review

References (37)

1. Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N. Engl. J. Med. 331, 489-495 (1994).
2. Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N. Engl. J. Med. 331, 496-501 (1994).
3. Peterson ED, Cowper PA, DeLong ER, Zidar JP, Stack RS, Mark DB. Acute and long-term cost implications of coronary stenting. J. Am. Coll. Cardiol. 33, 1610-1618 (1999).
4. Al Suwaidi J, Berger PB, Holmes DR Jr. Coronary artery stents. JAMA 284, 1828-1836 (2000).
5. Abizaid A, Kornowski R, Mintz GS et al. The influnce of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J. Am. Coll. Cardiol. 32, 584-589 (1998).
6. Kastrati A, Hall D, Schmig A. Long-term outcome after coronary stenting. Curr. Control Trials Cardiovasc. Med. 1, 48-54 (2000).
7. Stone GW, Ellis SG, Cox DA et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N. Engl. J. Med. 350, 221-231 (2004).
8. Moses JW, Leon MB, Popma JJ et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med. 349, 1315-1323 (2003).
9. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first generation drug-eluting stents: a cause for concern. Circulation 115, 1440-1455 (2007).
10. Lagerqvist B, James SK, Stenestrand U et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N. Engl. J. Med. 356, 1009-1019 (2007).
11. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur. Heart J. 27, 2784-2814 (2006).
12. Windecker S, Simon R, Lins M et al. Randomized comparison of a titanium-nitride oxide-coated stent with a stainless steel stent for coronary revascularization. The TINOX trial. Circulation 111, 2617-2622 (2005).
13. Karjalainen PP, Ylitalo A, Airaksinen KE. Real world experience with the TITAN stent: a 9-month follow-up report from the Titan PORI registry. EuroInterv. 2, 187-191 (2006).
14. Mosseri M, Miller H, Tamari I et al. The titanium-NO stent: results of a multicenter registry. EuroInterv. 2, 192-196 (2006).
15. Mosseri M, Tamari I, Plich M et al. Short and long term outcome of the Titanium- NO stent registry. Cardiovasc. Revasc. Med. 6(1), 2-6 (2005).
16. Giraud-Sauveur Y. Titan 2 bio-active stent (BAS) with titanium-NO. EuroInterv. 3, 526-528 (2007).
17. Karjalainen PP, Ylitalo A, Airaksinen JK. Titanium and nitride oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. J. Invasive Cardiol. 18, 462-468 (2006).
18. Karjalainen PP, Annala AP, Ylitalo A, Vahlberg T, Airaksinen KE. Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. Int. J. Cardiol. DOI: 10.1016/j.ijcard.2009.03.120 (2009) (In press).
19. Karjalainen PP, Ylitalo A, Niemel M et al. Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial. EuroInterv 4(2), 234-241 (2008).
20. Karjalainen PP, Ylitalo A, Niemela M et al. Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction. Ann. Med. 21, 1-9 (2009).
21. Steinemann SG. Metal implants and surface reactions. Injury 27, SC16-22 (1996).
22. Zhang F, Chen Y, Zheng Z et al. Synthesis and blood compatibility of rutile-type titanium oxide coated LTI-carbon. Sci. China C. Life Sci. 41(4), 400-405 (1998). (Pubitemid 128492112)
23. Zhang F, Zheng Z, Chen Y, Liu X, Chen A, Jiang Z. In vivo investigation of blood compatibility of titanium oxide films. J. Biomed. Mater. Res. 42(1), 128-133 (1998). (Pubitemid 28413005)
24. Yeh HI, Lu SK, Tian TY, Hong RC, Lee WH, Tsai CH. Comparison of endothelial cells grown on different stent materials. J. Biomed. Mater. Res. A 76, 835-841 (2006).
25. Tsyganov I, Maitz MF, Wieser E, Richter E, Reuther H. Correlation between blood compatibility and physical surface properties of titanium-based coatings. Surface and Coatings Technology 200, 1041-1044 (2005).
26. Tsyganov IA, Maitz MF, Richter E, Reuther H, Mashina AI, Rustichelli F. Hemocompatibility of titanium-based coatings prepared by metal plasma immersion ion implantation and deposition. Nucl. Instrum. Methods Phys. Res. B. 257, 122-127 (2007).
27. Windecker S, Billinger M, Hess OM. Stent coating with titanium-nitride-oxide for prevention of restenosis. EuroInterv. 2(2), 146-148 (2006).
28. Windecker S, Mayer I, De Pasquale G et al. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia. Circulation 104, 928-933 (2001).
29. Suzuki T, Kopia G, Hayashi S et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104, 1188-1193 (2001).
30. Sansa M, Cernigliaro C, Rosso R et al. Comparison randomisée de lutilisation de stents couverts au titane-nitride-oxyde dans lischémie aiguë: effets sur la thrombose précoce et tardive, et sur la resténose angiographique. Archives maladies du coeur et des vaisseaux 98(12) (2005).
31. SantAnna FM, Batista LA, Brito MB et al. Randomized comparison of percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus stainless steel stents in patients with coronary artery disease: RIO trial. Rev. Bras. Cardiol. Invas. 17(1), 69-75 (2009).
32. Lauterburg A, Ltscher S, Raeber L et al. Clinical outcome following PCI using titanium nitride oxide coated stents in complex patients, compared with Cypher-and Taxus-stents in a clinical registry. The BERN Registry. Presented at: TransCatherter Therapeutics. San Francisco, CA, USA, 21-25 September (2009).
33. Valdes M, Fernandez J, Bethencourt A et al. The TIBET Registry. Clinical and angiographic events in diabetes patients treated with the TITAN stent. Am. J. Cardiol. 94(Suppl. 6A), 47E (2004).
34. Valdesuso R, Karjalainen P, Garcia J et al. The EXTREME Registry: Titanium-nitride-oxide coated stents in small coronary arteries. Catheter. Cardiovasc. Interv. 76(2), 281-287 (2010).
35. Calvo I, Galache JG, Diarte JA, Sanchez-Rubio J. Clinical effectiveness of Titanium-NO stent in acute STEMI. Presented at: European Society of Cardiology Congress. Vienna, Austria, 1-5 September (2007).
36. Karjalainen PP, Biancari F, Ylitalo A et al. Pooled analysis of trials comparing titanium-nitride-oxide-coated stents with paclitaxel-eluting stents in patients undergoing coronary stenting. J. Invas. Cardiol. 22(7), 322-326 (2010).
37. Kaiser C, Brunner-La Rocca HP et al. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitts Trial (BASKET). Lancet 366(9489), 921-929 (2005).